Fierce Fatty Podcast cover image

156: Part 2: Is Wegovy/Ozempic the Miracle Weight Loss Drug It’s Made Out to Be? (Part 2)

Fierce Fatty Podcast

CHAPTER

Allegations of Misconduct in Insulin Pricing and Marketing

This chapter delves into the controversies surrounding Novo Nordisk's promotion of Victoza, including whistleblower claims of deceptive sales practices. It also highlights issues of price inflation and potential collusion among major insulin manufacturers, alongside legal repercussions for antitrust violations.

00:00
Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner